Status:
UNKNOWN
Bupivacaine Infiltration and Postoperative Pain
Lead Sponsor:
Armed Forces Hospital, Pakistan
Conditions:
Postoperative Pain
Local Infiltration
Eligibility:
FEMALE
20-40 years
Phase:
EARLY_PHASE1
Brief Summary
This is a double-blind randomized controlled trial to assess the efficacy of local infiltration of bupivacaine versus placebo, in reducing postoperative pain. The severity of pain will be assessed in ...
Detailed Description
Objective: To compare the effect of bupivacaine wound infiltration with placebo during caesarean section in terms of mean pain scores, analgesic requirement, and duration of hospital stay Introductio...
Eligibility Criteria
Inclusion
- pregnant women with age between 20-40 years, American Society of Anesthesiologist (ASA) class II, BMI \< 35 at the time of surgery, a period of gestation 37+0- 40+0 weeks, elective caesarean section done under spinal anesthesia, skin incision pfennensteil and lower segment transverse incision on the uterus.
Exclusion
- allergy to local anesthetic, emergency caesarean section, conversion of spinal anesthesia to general anesthesia, caesarean section due to abnormal placentation, midline skin incision, upper segment incision on uterus
Key Trial Info
Start Date :
January 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 10 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04728308
Start Date
January 10 2021
End Date
April 10 2021
Last Update
February 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Madiha Ahmed
Islamabad, Pakistan, 45710